新型小鼠模型重现经典胶质母细胞瘤自发成瘤
研究通过Cre介导在GFAP表达细胞中过表达EGFRvIII并纯合缺失p19-ARF(人p14ARF/CDKN2A同源物),培育出经典亚型胶质母细胞瘤小鼠模型;小鼠最早1月龄出现脑内/软脑膜病灶,95%于6月龄前死于脑积水或瘫痪,肿瘤分子特征与经典GBM一致并可异种移植成瘤。
要点
- EGFRvIII过表达联合p19-ARF缺失可在免疫健全小鼠中自发形成胶质瘤。
- 肿瘤分子特征与人类经典GBM相似,富集JAK/STAT与PI3K/AKT通路。
- 该模型可用于在完整免疫微环境中研究肿瘤发生与治疗。
核心结论
- 成功构建免疫健全的自发性小鼠胶质瘤模型,可模拟经典GBM发生并支持后续机制与治疗研究。
研究设计与样本
- 通过Cre介导在GFAP表达细胞中过表达EGFRvIII并纯合缺失p19-ARF(人p14ARF/CDKN2A同源物)培育小鼠模型。
- 对转基因小鼠脑病变进行免疫组化、批量和单细胞RNA测序及颅内异种移植验证。
主要发现
- 转基因小鼠最早1月龄出现脑实质和/或软脑膜病灶,95%于6月龄前死于脑积水或瘫痪。
- 免疫组化证实Cre表达细胞中EGFRvIII过表达和p19-ARF缺失,GFAP斑片状阳性、Ki67高增殖及H3K27me3缺失。
- 批量和单细胞RNA测序显示肿瘤与经典GBM聚类接近,JAK/STAT和PI3K/AKT通路下游标志物显著上调并存在瘤内异质性。
- 解离肿瘤细胞颅内注射NOD-SCID小鼠后3周内成瘤,特征与原发灶一致。
临床怎么用
- 该模型可用于在免疫健全微环境中评估针对经典GBM的新疗法。
- 肿瘤可异种移植传代,支持后续机制研究与临床前药效测试。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glioblastoma is the most common primary brain cancer in adults, with a poor prognosis and median survival of 15 months after treatment. Few in vivo transgenic models exist for testing new therapeutics. METHODS: A novel mouse model for the classical subtype of human glioblastoma (GBM) has been bred using Cre-mediated EGFRvIII overexpression and homozygous p19-ARF deletion, the mouse homolog of human p14ARF/CDKN2A, in GFAP-expressing cells. RESULTS: Transgenic mice developed intraparenchymal and/or leptomeningeal brain lesions as early as 1 month old and 95% of mice succumb to endpoint symptoms of hydrocephalus and/or paralysis by 6 months. Immunohistochemical analysis confirms EGFRvIII overexpression and p19-ARF loss in Cre-expressing cells, along with patchy positive GFAP and high proliferation by Ki67 as well as loss of H3K27me3. Bulk and single cell RNA sequencing revealed tumors cluster closely with classical GBM and have significant upregulation of downstream markers in the JAK/STAT and P13K/AKT pathways as well as intratumoral heterogeneity. Dissociated tumors generated xenograft tumors by 3 weeks post intracranial injections into NOD-SCID mice and were characteristic of the primary lesion. CONCLUSION: We developed a spontaneous, immune-competent murine glioma model that enables characterization of tumor development within an intact immune microenvironment and provides a resource for future mechanistic studies. Glioblastoma is the most common primary brain cancer in adults, and few animal models accurately reproduce how this aggressive tumor develops in people. The authors of this study wanted to create a new mouse model that closely mirrors the classical form of human glioblastoma so it can be used to test new treatments. To do this, they genetically engineered mice so certain brain cells produced high levels of a cancer-driving protein and lost a key tumor-suppressing gene, then analyzed how tumors formed and compared their biological features to human tumors. They found that most mice developed brain tumors within months, the tumors shared important molecular characteristics with classical human glioblastoma, and tumor cells from these mice were able to grow new tumors when implanted into other mice.
引用
- Singh O, Ellenbogen Y, Voisin M, et al. EGFRvIII overexpression and loss of mouse-specific CDKN2A in glial cells leads to spontaneous gliomagenesis in a novel mouse model. Neuro Oncol. 2026. PMID: 42921754. doi:10.1093/neuonc/noag175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。